Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,532 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A listener on a popular financial show asks whether a HELOC could erase credit card debt and fund a new car. The host...
Late-career workers who enroll in Medicare while still employed and continue HSA deposits risk a 6% annual excise tax...
A growing wave of retirees is trimming both living space and investment heft to align wealth with shifting priorities...
As SpaceX IPO chatter grows, investors seek breadth over a single-name bet. A diversified space ETF offers exposure t...
Ripple unveils its 2025 Impact Report, revealing more than $70 million in donations this year and a broader global pu...
NASA gears up a bold robotic rescue to preserve the aging Swift Observatory, a move that could influence space-tech i...
A large required minimum distribution can push high earners into higher Medicare surcharge brackets. Here's how it wo...
Enphase Energy and SolarEdge surged roughly 8% in morning trading as investors chase AI data-center power plays, exte...
New student loan rules take effect on July 1, redefining borrowing limits and repayment options for millions of borro...
May data show 7.6 million job openings, topping forecasts and signaling stabilization in the labor market. Thursday's...
Meta faced a pivotal near-miss in 2026 as it stepped back from a Kalshi deal. The decision highlights how regulatory ...